Monday, March 7, 2011
Supreme Court Won't Review Drug Patent Deal
WASHINGTON - The Supreme Court let stand a ruling that drug companies can pay rivals to delay production of generic drugs without violating federal antitrust laws.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment